Tirzepatide is an innovative dual GIP/GLP-1 receptor stimulator. This medication has shown exceptional results in clinical trials for the treatment of type 2 diabetes. By targeting both the GIP and GLP-1 receptors, tirzepatide efficiently improves insulin sensitivity. The dual mechanism of action of tirzepatide offers multiple potential advantages